David Mehalick
Listed on 13 Form D filings across 3+ issuers
· Executive Officer, Promoter
Associated issuers
- Nok Therapeutics, Inc. CIK 2038166 · PA
- CIK 2038185 CIK 2038185
- Coeptis Therapeutics Holdings, Inc. CIK 1759186 · PA
Filings (13)
-
Nok Therapeutics, Inc.D · May 1, 2026 · PA · Biotechnology$3.2KView filing →
-
Nok Therapeutics, Inc.D · May 1, 2026 · PA · Biotechnology
-
Nok Therapeutics, Inc.D · Apr 22, 2026 · PA · Biotechnology$750KView filing →
-
Nok Therapeutics, Inc.D · Apr 22, 2026 · PA · Biotechnology
-
Nok Therapeutics, Inc.D · Apr 22, 2026 · PA · Biotechnology$1.4KView filing →
-
CIK 2038185D · Mar 26, 2026 · Biotechnology
-
Nok Therapeutics, Inc.D · Mar 26, 2026 · PA · Biotechnology$1.4KView filing →
-
CIK 2038185D · Oct 28, 2025 · Biotechnology
-
Nok Therapeutics, Inc.D · Oct 24, 2025 · PA · Biotechnology$750KView filing →
-
Nok Therapeutics, Inc.D · Oct 24, 2025 · PA · Biotechnology
-
CIK 2038185D · Oct 21, 2025 · Biotechnology$3MView filing →
-
CIK 2038185D · Oct 21, 2025 · Biotechnology
-
Coeptis Therapeutics Holdings, Inc.D · Aug 7, 2025 · PA · Pharmaceuticals$5MView filing →